Chemomab Therapeutics (CMMB) announced the successful completion of its End-of-Phase 2 Meeting with the FDA and alignment with FDA on the ...
A Centers for Disease Control and Prevention vaccine advisory committee meeting scheduled for next week — the first since ...
A panel of experts that advises the Centers for Disease Control and Prevention on vaccine policy will not meet as previously ...
The cuts at the FDA’s device center could add “months, if not years” to the time it takes to bring products to market, an ...
As the second Trump administration settles in, the U.S.' top pharmaceutical trade group is drafting its ambitions for the ...
GSK's Penmenvy wins FDA approval to protect against five meningococcal serogroups. The CDC panel will vote on usage ...
Each year, flu experts from around the world gather to map out recommendations for next winter's flu vaccine. This year, it's ...
WASHINGTON (AP) — The Trump administration’s effort to slash the size of the federal workforce reached the Food and Drug ...
With massive terminations, data removals, holds on U.S. government funding, cancellation of various programs and meetings, the potential for 25% tariffs on medical products and a multitude of court ...
The Food and Drug Administration (FDA) and Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) met on Tuesday to optimize the facilitated review pathway (FRP) to expedite access to essential ...
Shares of Travere Therapeutics (NASDAQ:TVTX) surged 14% Tuesday following the company's announcement of a successful Type C ...